Logo of Nahdi Medical Co.
Saudi Arabia’s Nahdi Medical Co. seeks about SAR 4.9 billion ($1.3 billion) through a potential initial public offering (IPO), Bloomberg reported, citing sources familiar with the matter.
The Kingdom's largest pharmacy retail chain appointed HSBC Saudi Arabia and SNB Capital to manage the sale of a 30% stake on the Saudi stock market, the sources said, adding that the company seeks a valuation of around SAR 16 billion ($4.3 billion) in the IPO.
In December 2021, the Capital Market Authority (CMA) approved Nahdi's application to float 39 million shares, representing 30% of its share capital, Argaam earlier reported.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}